Synergistic Enhancement of Photodynamic Cancer Therapy with Mesenchymal Stem Cells and Theranostic Nanoparticles
Authors:
- Aleja Marija DaugelaiteADAleja Marija Daugelaite
- Vilius PoderysVPVilius Poderys
- Riccardo MarinRMRiccardo Marin
- Simona SteponkieneSSSimona Steponkiene
- Evelina KazlauskeEKEvelina Kazlauske
- Ilona UzielieneIlona Uzieliene
- Dainius DaunoraviciusDDDainius Daunoravicius
- Daniel JaqueDJDaniel Jaque
- Artiom SkripkaASArtiom Skripka
- Fiorenzo VetroneFVFiorenzo Vetrone
Open Access
- 10 September 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (37) , 49092-49103
Abstract
Nanoparticles engineered to combat cancer and other life-threatening diseases may significantly improve patient outcomes. However, inefficient nanoparticle delivery to tumors limits their use and necessitates the development of complex delivery approaches. Here, we examine this issue by harnessing the tumor-homing abilities of human mesenchymal stem cells (MSCs) to deliver a decoupled theranostic complex of rare earth-doped nanoparticles (dNPs) and photosensitizer chlorin e6 (Ce6) to tumors. We show that both bone-marrow- and skin-derived MSCs can transport the dNP-Ce6 complex inside tumor spheroids, which is challenging to accomplish by passive delivery alone. MSCs deliver the dNP-Ce6 complex across the tumor spheroid, facilitating more effective photodynamic damage and tumor destruction than passively accumulated dNP-Ce6. The dNP-Ce6 complex also provides the built-in ability to monitor the MSC migration without causing undesired phototoxicity, which is essential for maximal and side-effect-free delivery of nanoparticles. Our results demonstrate how MSCs can be used as delivery vehicles for the transportation of the dNP-Ce6 complex, addressing the limitations of passive nanoparticle delivery and providing light-based theranostics.Keywords
Funding Information
- Lietuvos Mokslo Taryba (S-MIP-22-31)
- Ministerio de Ciencia e Innovaci?n (NANONERV PID2019-106211RB-I00, RYC2021-032913-I)
- Natural Sciences and Engineering Research Council of Canada (Discovery Accelerator Supplement award)
- Fonds de Recherche du Qu?bec - Nature et Technologies
- European Union?s Horizon 2020 (895809 (MONOCLE))
This publication has 52 references indexed in Scilit:
- Mesenchymal stromal/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: A new strategy to overcome cell therapy limitationsBiomedicine & Pharmacotherapy, 2022
- Mesenchymal stem cells transporting black phosphorus-based biocompatible nanospheres: Active trojan horse for enhanced photothermal cancer therapyChemical Engineering Journal, 2020
- Decoupling Theranostics with Rare Earth Doped NanoparticlesAdvanced Functional Materials, 2019
- 3D cellular spheroids as tools for understanding carboxylated quantum dot behavior in tumorsBiochimica et Biophysica Acta (BBA) - General Subjects, 2018
- Mesenchymal Stem Cells Derived from Human Adipose Tissue2015
- Stem Cells Loaded with Nanoparticles as a Drug Carrier for In Vivo Breast Cancer TherapyAdvanced Materials, 2014
- The Size of Mesenchymal Stem Cells is a Significant Cause of Vascular Obstructions and StrokeStem Cell Reviews and Reports, 2014
- Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticlesBiomaterials, 2011
- The pH-dependent distribution of the photosensitizer chlorin e6 among plasma proteins and membranes: A physico-chemical approachBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Chlorin e6-liposome interaction. Investigation by the methods of fluorescence spectroscopy and inductive resonance energy transferJournal of Photochemistry and Photobiology B: Biology, 1990